We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Expression of Recombinant Human Programmed Cell Death Protein-1 and Development of Camel Polyclonal Antibody
PeriodicalsMedical Sciences

Expression of Recombinant Human Programmed Cell Death Protein-1 and Development of Camel Polyclonal Antibody

Checking your access to this record.

Abstract & Overview

Aims Programmed cell death protein-1 (PD-1) is a membrane receptor expressed on the surface of T and B lymphocytes, monocytes, natural killers, and dendritic cells. In cancer, the PD-1/PD-L1 system prevents the proliferation of T lymphocytes and causes the release of cytokines and cytotoxicity, which leads to the apoptosis of tumor-specific T cells, thereby preventing the immune response to cancer cells. Methods & Materials In this study, the extracellular part of the humanized PD-1 protein was cloned and expressed, and the protein was injected as an antigen into a camel (Camelus dromedarius) to obtain a camel polyclonal antibody against PD-1 protein. Findings The obtained results indicate the proper expression of the protein in the prokaryotic system. Also, using various tests, such as ELISA and western blot, it was confirmed that the polyclonal antibody obtained from camel can identify PD-1 protein. Conclusion This study showed that because of the advantages, such as the ability to bind multiple epitopes, camel polyclonal antibodies can be used in antibody-based research for effective and strong molecular applications to detect PD-1 receptors.

Cite this record

Mohammad Hosseininejad-Chafi, Zahra Kianmehr, Kamran Pooshang Bagheri, Fatemeh Kazemi‐Lomedasht, Mahdi Behdani (2022). Expression of Recombinant Human Programmed Cell Death Protein-1 and Development of Camel Polyclonal Antibody. Internal medicine today, 28(4), 498–513. https://doi.org/10.32598/hms.28.4.3858.1

Copy in another style

Hosseininejad-Chafi, M., Kianmehr, Z., Bagheri, K. P., Kazemi‐Lomedasht, F., & Behdani, M. (2022). Expression of Recombinant Human Programmed Cell Death Protein-1 and Development of Camel Polyclonal Antibody. Internal medicine today, 28(4), 498–513. https://doi.org/10.32598/hms.28.4.3858.1
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.